
The longevity treatment no one’s talking about: Peter Attia, M.D. | mbg Podcast
What this covers
The conversation is between host Jason and physician Peter Attia, and it starts from cardiovascular disease as the leading cause of death worldwide, ahead of cancer. Attia places it among The Four Horsemen of chronic disease. He describes a heart attack as a slow death disguised as a fast death, the end of 20-30 years of buildup. He also contests the standard-of-care approach, which uses a 5-10 year risk calculator and treats only above a 5% five-year risk. In his view, nearly everyone has some microscopic atherosclerosis, so that horizon is too short.
The middle of the episode is technical. Attia defines apoB) as a count of atherogenic particles, one per particle. He calls it necessary but not sufficient for atherosclerosis. He argues that reaching very low levels in most adults takes drugs, and he walks through ezetimibe, PCSK9 inhibitors, and bempedoic acid, including their rough out-of-pocket costs. He also covers Lp(a) and ApoE testing, the rise in apoB after menopause, and why women should fear heart disease far more than breast cancer. Blood pressure gets its own stretch: a 120/80 target drawn from the SPRINT trial, kidney damage as an underrated consequence, correct home measurement technique, and sleep apnea screening.
The last third turns to daily practice. Attia says the 0.8 g/kg protein RDA is a floor and recommends roughly 1.5-2.0 g/kg spread over several meals. He notes that a crowded, short-rest gym session trades strength for metabolic strain. He treats VO2 max and strength as things only deliberate training produces. He explains why grip strength works as a longevity proxy, and he admits that the molecular effects of exercise remain largely unmeasurable.
Attia argues that exercise, muscle mass, and strength are the single most important determinants of longevity and healthspan, with measurable hazard ratios exceeding those of treating other risk factors, while lifestyle optimization (nutrition, sleep, stress) and targeted pharmacotherapy (apoB-lowering drugs) are necessary but secondary to consistent training.
- Hazard ratios for high cardiorespiratory fitness, muscle mass, and strength exceed those of treating high blood pressure, high apoB, type 2 diabetes, and smoking
- Exercise reduces all-cause mortality risk by 50% when moving from zero to 3 hours per week
- ApoB is necessary but not sufficient for atherosclerosis; lowering it requires both lifestyle and pharmacotherapy in most adults
This asset isn't compiled yet
You're seeing its claims, ranked. Compile it to build the argument threads, weight them, and check each claim against your library — the full view.
Food provides raw materials for energy and structure, but humans evolved in scarcity with genetic prioritization for storage and avoiding starvation, not handling abundance; modern overabundance presents novel problems evolution didn't prepare us for, requiring counterintuitive solutions.
“we are clearly in a world today where all of our remarkable genes and adaptations are not necessarily serving us as well as they did over millions of years leading up to this point. In other words, we've spent most of our, um, genetic existence honing our relationship to nutrition in a scarcity environment. So, the prioritization was on storage. And the prioritization was on avoiding calamitous outcomes. Um, starvation will kill you quickly. Overabundance of nutrition will kill you very, very slowly. So, given that we're in a world where most people are overexposed to nutrition, um it's presenting us with a whole bunch of new problems that evolution didn't really have a chance to prepare for.”
Women are 8-10 times more likely to die from cardiovascular disease than from breast cancer, despite widespread fear of breast cancer.
“for as as understandable as it is that a woman would be afraid of breast cancer, um you know, she's somewhere between eight and 10 times more likely uh to die from cardiovascular disease uh than she is from breast cancer.”
Achieving apoB of 20-30 mg/dL in adults would require either draconian unsustainable dietary modifications (living on lettuce and celery) or pharmacotherapy; genetics, nutrition optimization, and lifestyle alone cannot achieve this in most adults even with full optimization.
“outside of perhaps the most draconian dietary, you know, modifications that would not be sustainable, right? So, you know, just living on lettuce and celery, for example, um it basically would require pharmacotherapy to get your apoB that low. So, there's obviously great heterogeneity genetically, um and absolutely uh nutrition makes a difference... but but even once those things are fully optimized, very few people would be able to get their apoB below, say 70 mg per deciliter, with those things being fully optimized as adults.”
RDA (recommended dietary allowance) for protein of 0.8 g/kg is misleading as minimum to avoid wasting, not optimal intake; for health and fitness goals, optimal protein is 1.2-2.2 g/kg, with most people advised 1.5-2.0 g/kg spread over 3-4 meals daily.
“The RDA, uh, which is the recommended dietary, uh, allowance is misleading and frankly, it's incorrect. So, the RDA stipulates something to the tune of 0.8 g of protein per kilogram of body weight and that has been misinterpreted as the ideal amount of protein intake when in reality, it's sort of the bare minimum to not wither away... we're talking about at least 1.2 g of protein per kilogram of body weight and frankly, up to about 2.2... we kind of tell patients, look, you really want to be in the 1.5 to 2 g of of protein per pound of body weight camp and you want to be getting that spread out over three to four servings per day.”
ApoB is a necessary but not sufficient criterion for atherosclerosis—you cannot have atherosclerosis without apoB, therefore eradicating apoB early enough in life would eradicate atherosclerosis.
“apoB is a necessary, but not sufficient criteria for atherosclerosis. What that means is you can't get atherosclerosis without apoB. So, the implication of this is actually profound. The implication of this is if you want to eradicate atherosclerosis, all you would have to do is eradicate apoB. Now, of course, you'd have to do that early enough in life because it's a time exposure.”
Blood pressure management is critical not just for cardiovascular disease and dementia prevention, but also—and perhaps most importantly—for kidney preservation; high blood pressure damages the kidney's microscopic capillaries, which receive 20-25% of cardiac output despite being only 2% of body weight, causing premature kidney aging (e.g., 40-year-old kidneys at age 60).
“It does play an incredible role in both uh cardiovascular disease and neurodegenerative disease, specifically Alzheimer's disease, but all causes of dementia. Um including vascular dementia. And if that weren't enough, even if it had no bearing on your heart and brain, and it's hard to think of two organs that, you know, we wouldn't want to do without, um its impact on the kidney is perhaps even more important and often more undetected.”
A person doing resistance training in a busy gym with minimal rest, spending more time in cardio-taxed work (high metabolic demand), makes trade-offs: they won't develop as much strength or muscle mass as someone providing adequate rest to the muscles, because insufficient mechanical stress is placed on muscle despite elevated metabolic/cardio output.
“Depends what you're optimizing for. Um I I don't think that weight training is a great way to get your zone two in. I think zone two is best achieved through steady-state cardio, which could be you know, running, swimming, riding a bike, climbing a stair master, doing all those sorts of things. Um and again, if you're doing your weights on really, really short intervals such that the cardio aspect of it is what becomes taxing, that's great, but you just have to accept and acknowledge that you are going to make trade-offs, right? You are not going to get as strong as you otherwise would and you won't necessarily put on as much muscle mass because you're not providing enough stress to the muscle as you would if you gave more rest.”
Major lifestyle interventions for blood pressure are exercise (especially cardio training more than strength training), sleep (7-9 hours, ruling out sleep apnea via STOP-BANG test), weight loss, and stress reduction; sleep apnea occurs in thin metabolically healthy people and is underdiagnosed.
“Exercise, weight loss, sleep, and stress reduction are the big ones. Those have All of those have significant impact on blood pressure. Um And so on the exercise front, it seems specifically more around uh cardio training than strength training... Um and it doesn't have to be insanely intense, right? It's you know, the kind of the zone two training... Thin people, metabolically healthy people can still have sleep apnea even though it's less common. So, you have to make sure you don't have sleep apnea.”
ApoB (apolipoprotein B) is a protein wrapped around atherogenic lipoproteins (LDL, VLDL, IDL, Lp(a)) that carry cholesterol into artery walls, become oxidized, and trigger inflammatory atherosclerotic response; each atherogenic particle has exactly one apoB, making apoB measurement a direct count of atherogenic particle concentration.
“apoB is is a protein that is wrapped around lipoproteins, but particularly a class of lipoproteins that are harmful. They're what we call atherogenic, meaning that they promote atherosclerosis... each atherogenic particle has one and only one apoB on its surface. So, by measuring the concentration of apoB, you have a direct measurement of the concentration of atherogenic particles.”
Menopause causes significant increases in apoB in women as estrogen levels decline, explaining premenopausal cardiovascular protection in women and the observed convergence of women's cardiovascular risk to men's levels postmenopausally.
“This gets particularly more difficult in women when they go through menopause, because the reduction of estrogen further complicates this, and so women will typically see a significant bump in their apoB as they transition through menopause, and this explains two things. One, premenopausal women have some protection from cardiovascular disease that some of which might be mitigated mediated through estrogen. And secondly, eventually women kind of catch up in terms of heart disease once they lose the protection of estrogen, which of course isn't complete protection, but sort of partial protection.”
ApoE genotype should be tested in all individuals; ApoE4 is high-risk isoform for Alzheimer's disease but is not deterministic—carriers of one or two copies are at increased risk and should take preventive precautions similar to genetic breast cancer screening.
“I think everybody should know their ApoE genotype. Um that that certainly gives us some additional information about the risk of cardiovascular disease and perhaps more importantly the risk of Alzheimer's disease. Um I think that knowing that information can be actually very important as you think about how to take steps to prevent uh or at least significantly delay the onset of Alzheimer's disease... If you have ApoE4, four is the isoform that is the high-risk isoform. If you have one or two copies of the ApoE4, it's not uh it's not a given that you're going to get Alzheimer's disease, but you are at increased risk and therefore one should take, you know, precautions. It's sort of like saying, you know, if you if you had a gene that knew you were more susceptible to lung cancer, knowing that would be very valuable if you were ever tempted to smoke.”
Lipoprotein(a) [Lp(a)] is a genetic cardiovascular risk factor that cannot be substantially modified by lifestyle interventions, only pharmacologically; high Lp(a) is heritable and requires testing.
“we briefly touched on LP little A, which is also a must-have test for anyone concerned about cardiovascular disease. And as you pointed out, that that's one you really can't move the Well, you can pharmacologically help, but you're kind of stuck with what you have and some people are in are are born with higher LPA.”
Blood pressure target should be at or below 120/80 mmHg based on the SPRINT trial, which demonstrated significant health advantage of 120/80 versus the previously considered normal 130/85.
“My data here are very actually are quite in line with the medical establishment as established by the most recent enormous trial on this called the Sprint trial. The Sprint trial Sprint trial demonstrated the significant advantage of keeping blood pressure at or below 120/80 even relative to say 130/85 which used to be considered normal.”
Moving from zero exercise to 3-4 hours per week reduces all-cause mortality risk by 50%, meaning at any moment the exerciser's risk of dying in next year is 50% less than their non-exercising former self.
“if you look at the reduction in risk that comes from going from doing zero exercise to doing 3 hours a week, which is a little less than what this person will end up doing, right? This is a person who's probably going to get to 4 hours a week of exercise. But, just going from zero exercise to four to 3 hours a week is going to reduce your risk of all-cause mortality by 50%. What that means in English is making that change from no exercise to 3 hours a week means that at any moment in time, your risk of dying in the next year is 50% less than a person who's not exercising.”
PCSK9 inhibitors, ezetimibe, and bempedoic acid are the three main non-statin lipid-lowering drugs: PCSK9 inhibitors reduce LDL particle clearance; ezetimibe blocks cholesterol reabsorption in the gut via the liver; and bempedoic acid is a liver-specific cholesterol synthesis inhibitor (unlike statins which act globally), with typical out-of-pocket costs of ~$500/month for PCSK9 inhibitors and bempedoic acid.
“Uh PCSK9 inhibitors uh and then ezetimibe and bempedoic acid. And they don't have side effects. No. The bempedoic acid is a is a cholesterol synthesis inhibitor, but it's it's a prodrug that is metabolized by the liver and therefore only impairs cholesterol synthesis in the liver, whereas statins kind of do it globally. And that's probably why 5% of people experience side effects to statins cuz it's acting quite globally. And how expensive are those three drugs? Well, ezetimibe is not terribly expensive, but a PCSK9 inhibitor and bempedoic acid, if you pay for them out of pocket, if your insurance company would not approve them, would be $500 a month.”
Even if a person dies of something other than the four horsemen, autopsy will reveal some degree of atherosclerotic progression; therefore everyone has CVD at the microscopic level, making universal apoB management philosophically justified and explaining why the current standard-of-care 5-10 year risk calculator is inadequate.
“If we take a step back and say everyone has CVD, no matter what age you are, you do have, you pointed this out in the book, too. Even if you die of, you know, 99 of of something else, when they open you up, there is Yeah, every everybody dies with it. A number of people die from it.”
Cardiovascular disease and cerebrovascular disease deaths in the United States are approximately 20-30% higher than cancer deaths, representing the number one killer for both men and women globally, with 19 million cardiovascular deaths versus 11-12 million cancer deaths.
“in the United States, you know, it it is in excess of, you know, cardiovascular death um and cerebrovascular disease death, those are, you know, probably on the order of uh 30%, 20% more than the deaths attributed to cancer. When you think about it globally, it's even more profound. In other words, the gap between heart disease and and in the number two killer, cancer, is even bigger. Uh we're talking about 19 million versus about 11 or 12 million.”
Exercise is the ultimate elixir of longevity—not opinion but fact—because hazard ratios for high cardiorespiratory fitness (VO2 max), muscle mass, and strength are so far in excess of hazard ratios for even high apoB, type 2 diabetes, and smoking that exercise is the single most important health intervention.
“if you look at all of the metrics that are associated with longevity, there are none that even come within the same zip code as having a very high cardiorespiratory fitness measured by VO2 max and having high muscle mass and having high strength. The hazard ratios associated with those things are so far in excess of the hazard ratios associated with everything else that we already know is harmful, such as having high blood pressure, having even having high apoB, having type 2 diabetes, um smoking.”
Even deaths that appear sudden (like a heart attack) represent decades of underlying disease process—at least 20-30 years of slow atherosclerotic buildup—making cardiovascular disease a slow death masquerading as fast death.
“Even if someone drops dead suddenly from a heart attack, and you say, 'Well, gosh, that was very sudden. That was a very fast death.' It wasn't. The process was going on for decades. At least, you know, 20 or 30 years, this was slowly building.”
Current standard of care for cardiovascular prevention uses 5-10 year risk horizon calculated from risk calculators estimating major adverse cardiac events (MACE: heart attack, stroke, death), with guideline threshold of treating only if 5-year risk ≥5%; Attia disagrees fundamentally with this time horizon and threshold.
“the current standard of care is only to treat preventatively for cardiovascular disease with respect to lipid management based on a 5-to-10-year risk time horizon. So, there are a number of risk calculators that estimate a person's 5-to-10-year risk of what's called a major adverse cardiac event, so a heart attack, stroke, death. And the general guideline says unless that level reaches 5%, the the cost of treating is not worth it. Now, I disagree with that simply and fundamentally, and I could debate all the reasons why, and I think I do so in the book, uh hopefully well. But But that's the first part of it is I fundamentally disagree that a 5-to-10-year risk horizon is adequate. I think we should be looking at lifetime risk.”
Accurate blood pressure measurement requires: arm at exact heart level (not above/below), 5 minutes rest before measurement, no talking, legs uncrossed; office measurements are often inaccurate due to white coat hypertension and improper technique; home monitoring twice daily is most reliable assessment method.
“I don't think most people know their blood pressure and when you go to the doctor's office, you're not really getting an accurate blood pressure. You're you know, you're very likely to be susceptible to white coat hypertension. Um and even if you're not, rarely is a protocol correctly used for measuring blood pressure. Um it's very important where your arm is in relation to your heart. It has to be at the exact same level. Can't be above it. Can't be below it. You need to be resting for 5 minutes before you have the blood pressure checked. You can't be talking. You can't have your legs crossed. You know, all of these things have to be done. And we find the only way to really do this with our patients is frankly just to have them do it at home twice a day every day and keep a a long log.”
Grip strength is a proxy for longevity because: (1) it's objectively measurable and reproducible across labs, (2) it reflects overall strength and physical robustness, (3) strong grip requires heavy loading and physical competence, (4) weak grip indicates weakness in kinetic chain (lats to scapula to elbow to wrist to hand).
“So VO2 max because is is one, it's we measure it. It's something that's relatively easy to measure. It's very objective. Um But also, it speaks to a type of training. To have a high VO2 max is not just something you wake up with. You have to train to get it. And similarly, grip strength is relatively easy to measure. It's something that can be, you know, done very objectively from lab to lab, person to person. And it also tells you something about a person. Right? People that have a very strong grip are generally very strong people. They're usually people who carry very heavy things... So I think that grip strength has some obvious benefits, which is our hands are, you know, two of the four most important things we use to interact with the outside world. So if your grip is weak, everything becomes compromised... if your grip is strong, I know that you are physically robust because you have to be doing something to enable a strong grip.”
Only way to achieve high VO2 max, high muscle mass, and high strength is through training that produces those specific adaptations; these are not passive benefits of genetics or lifestyle but require deliberate training.
“the only way to achieve those metrics, that is to say to have high muscle mass, to have high strength, to have high VO2 max, is to do the training that produces those things.”
Measurement tools for exercise effectiveness are crude; while fitness (VO2 max) and strength are measurable, underlying mechanisms (gene transcription, methylation patterns, epigenetic changes) cannot yet be measured and researchers don't know what to look for, limiting ability to monitor exercise's deeper benefits.
“The tools that we can use to measure the effectiveness or efficacy of various interventions are crude. Like, we don't have very good biomarkers for the benefits of these things... we're not seeing what the gene transcription looks like. We're not seeing what the methylation pattern or epigenetic changes look like. And we don't know, frankly, what to look for, anyway, right? So, we we certainly have the technology to measure those things, but we don't know what we're looking at.”
As people age they experience anabolic resistance, requiring higher protein intake to maintain muscle; older individuals should be at higher end of protein spectrum (1.5-2.2 g/kg) compared to younger people.
“as a person gets older, they experience something called anabolic resistance. We need to push them to the higher end of that spectrum.”
Children are born with apoB levels of 20-30 mg/dL (physiologic levels), but by ages 20-30 the average adult apoB is 100-110 mg/dL, with only 20% of adults having apoB below 80 mg/dL, representing a dramatic shift from childhood to pathogenic adult levels.
“when children are born, their apoB is very low. It's typically on the order of 20 to 30 mg per deciliter. However, by the time you're in your 20s, and certainly in your 30s, the average person's apoB is about 100 to maybe 110 mg per deciliter. And that's already very high from the standpoint of prevention. In fact, only 20% of adults would have an apoB below 80 mg per deciliter.”
Lipid-lowering pharmacotherapy history: cholesterol-heart disease link identified ~1960, early treatments failed, statins introduced 1980s (~40 years ago) with benefit but high side effects, limiting prophylactic use; modern era (since ~2015) has seen development of PCSK9 inhibitors, ezetimibe, and bempedoic acid with minimal side effects.
“if you go back to the first realization that lowering lipids was valuable, this is circa 1960 was when it became pretty clear that there was something going on between the cholesterol in your blood and the cholesterol that could be measured, you know, indirectly in your blood via these lipoproteins and your risk of heart disease. But the early efforts to try to treat that were abysmal failures. It really wasn't until the introduction of statins that which occurred in the 1980s, so called 40 years ago, that we really started to see a benefit... And so what we have today are not just statins that have much better side effect profiles. They still, by the way, cause side effects in about 5% of people. But we have other classes of drugs called PCSK9 inhibitors um or another drug called ezetimibe that blocks the reabsorption of um cholesterol in the gut that is being recirculated by the liver. And even another drug that impairs cholesterol synthesis called bempedoic acid. These are drugs that have no side effects.”
DEXA scanning and appendicular lean mass index (fat-free mass index) allow objective assessment of muscle mass; adequate muscularity is defined as ≥75th percentile for sex and age on nomogram, based on unambiguous data on longevity and health benefits of adequate muscle mass.
“we use a DEXA scan to tell us. And we use something called the appendicular lean mass index or the fat-free mass index, where we very objectively look at the amount of muscle mass or lean mass that they have, and we put it on a nomogram that is percentiled by their sex and age. And we like to see people we would consider adequately muscled to be 75th percentile and higher. And that's based on the the data that are pretty unambiguous about the longevity and health benefits of having adequate muscle mass.”
Best way to improve grip strength is carrying heavy objects (farmer carries, carrying dumbbells) not grip squeezers; carrying allows progression from subbody weight loads for beginners to multiple times body weight for advanced trainers (e.g., deadlifting 2x body weight).
“the way to improve that is carry heavy things, walk around with dumbbells. That's how we get there. Yeah, farmers carries, pull-ups, dead hangs. Again, there's lots of ways. I mean, carrying is hands down the most beneficial way to strengthen your grip because you don't you can carry less than your body weight. So, when a person is starting out, they don't have to carry enormous amounts of weight. And obviously, as you get stronger and stronger, I mean, you know, a person can, you know, easily deadlift twice their body weight.”
Smoking 10-fold increases risk of lung cancer, used as parallel example to establish the causal relationship paradigm for other health risks like apoB and cardiovascular disease.
“smoking tenfold increases your risk of lung cancer”
Most physicians are unaware of the apoB discussion and evidence about aggressive lipid lowering. This is not a matter of pharmaceutical company failure to develop drugs, but a matter of physician and patient education. Most physicians think aggressive apoB lowering is 'too aggressive' and don't understand the temporal (lifelong) nature of atherosclerosis causation.
“the truth of it is I think most physicians aren't aware of the discussion we're having. I mean, most physicians would think that this I mean, I'll I'll tell you a very common discussion I have with physicians.”
Exercise alone can produce significant apoB reductions but effect is highly variable; Jason's example of reduction from 91 to 75 mg/dL with increased strength training and no dietary change is unusually large and may reflect individual variation rather than typical response.
“there's there's so much variation in it that we can't it's hard to make a a distinction based on one measurement. Um but I would say that a reduction from 90 to 75-ish would be if it were reproducible, would be uh a very unusual response to just changing exercise.”
Modernity is accelerating slow death through over-nourishment, under-muscling, under-sleeping, and over-stressing, creating a scenario where we avoid fast death but become intoxicated by conditions accelerating slow death, requiring threading a needle to live longer at higher quality.
“we also know that modernity itself is probably accelerating fast death, uh pardon me, slow death greatly through all of the things that you mentioned. So, we're clearly over-nourished, we're under-muscled, we're under-slept, we're over-stressed. All of those things dramatically, directly, and indirectly impact our state of health. So, there is clearly a scenario whereby we can avoid the pitfalls of fast death, which is, of course, the most important benefit of modernity, but not be so intoxicated by all of the other things that come with it that I think there's a needle to thread where we can live a bit longer and, more importantly, live at a much higher quality than we do.”
The 'four horsemen' causes of death are: (1) cardiovascular disease, (2) cancer of all causes, (3) neurodegenerative disease (primarily Alzheimer's but including Parkinson's, Lewy body dementia, vascular dementia, frontotemporal lobe dementia), and (4) a spectrum of metabolic diseases (hyperinsulinemia, insulin resistance, fatty liver disease, type 2 diabetes) that dramatically amplify risk of everything else.
“cardiovascular disease is number one, cancer of all causes is number two, and then basically number three, for a non-smoking population, is going to be uh neurodegenerative disease... And then we also have forms of dementia that fit kind of outside of the neurodegenerative pathway, such as vascular dementia and uh frontotemporal lobe dementia and things like that. So, the final horseman is less a single disease and more a spectrum of diseases that directly don't kill that many people relative to those three horsemen, but indirectly might be the single greatest killer of them all because it amplifies the risk of everything else dramatically. And that's the the suite of metabolic diseases that ranges from at one end of the spectrum, hyperinsulinemia, elevated levels of insulin, insulin resistance, fatty liver disease, and at the other end of the spectrum, type 2 diabetes.”
Medicine 2.0 (scientific era beginning late 19th century) solved 'fast death' (trauma, infections) that killed humans for millions of years, increasing life expectancy from ~40 to ~80 years over 100 years, but has not addressed 'slow death' from the four horsemen despite that representing the majority of modern mortality.
“medicine 2.0, which is the era we live in now, has been remarkable at dealing with what I describe in the book as fast death... the advent of medicine 2.0, which really kind of took hold in the latter part of the 19th century... Those three things basically heralded in a new era. And all of a sudden, we were in a very short period of time, meaning in a matter of decades, we were able to reduce the rate of slow death, pardon me, of fast death, so much so that we effectively doubled mortal doubled life expectancy. So, over the past 100 years, we've watched our life expectancy go from about 40 to about 80... but in that period of time, as you point out, we haven't really made much success, if any, against slow death.”
Nutrition assessment requires answering three questions in sequence: (1) Is person under- or over-nourished? (2) Are they under- or adequately muscled? (3) Are they metabolically healthy? Only after these answers determines if intake should decrease, increase, or stay same.
“my my philosophy is it always starts with three questions. Um so, if I'm if I'm looking at a person and trying to figure out or help them figure out how they ought to be eating, I want to know if they're undernourished or overnourished... The next question is, are they over or under muscled?... And then the third question is, are you metabolically healthy or not?... when you have answers to those three questions, then you have a plan in place for nutrition. And the first-order question is, do you need to reduce intake, yes or no, relative to current baseline?”
Laboratory reference ranges (typically 5th-95th percentile of tested population) are misleading for health assessment because they reflect the current unhealthy population median, not physiologically appropriate values; transaminases (AST, ALT) are examples where stringent ranges are more appropriate than lab reference ranges.
“when you look at a lab test and it says a normal range is, you know, 20 to 45, what it's usually showing you is the 5th to 95th percentile of the population currently as being tested. But if we acknowledge that I don't know, 50% of the population is pretty unhealthy, if not more, do we really want to be compared to the middle of that population bell curve? We we don't. So, you know, transaminases, AST and ALT, are great examples of that, where if you, you know, for example, we don't hold our patients to the standard of the lab reference range. We we're using more stringent ranges.”
For time-constrained person with 30 min/day exercise capacity (4 hours/week), recommended split is ~50/50 resistance and cardio: Monday/Wednesday/Friday 30 min strength, Tuesday/Thursday 30 min cardio, weekend 1 hour cardio, producing ~4 hours/week total.
“For that individual, I would probably keep it very simple and make it a 50/50. So, I I say during the week, Monday, Wednesday, Friday, do 30 minutes of strength. Tuesday, Thursday, do 30 minutes of cardio, and on the weekend, do that hour session as cardio.”
What health and wellness needs is more 'back to basics' approach; many people promoting longevity use sci-fi rhetoric about immortality and genetic engineering while neglecting basic health practices, and people should 'major in the major and minor in the minor' rather than obsessing over phytonutrients while ignoring VO2 max.
“Hm, it's a good question. You know, probably just more back to basics. I I I do and it very very much depends on who we're talking about, but I still think there's a little bit of the science fiction approach to longevity that is kind of you know, we're going to we're going to sci-fi our way into immortality. Um, and I think that's just sort of ironic given that a lot of the people who are talking that way are some of the least healthy people uh, just in terms of ostensible health and not taking advantage of the things that we have right in front of us that are, you know, significantly going to move the needle for our own health. So, I suppose that I'd like to see more of that and and frankly, I'd like to see people major in the major and minor in the minor instead of the reverse. There's a lot of majoring in the minor and minoring in the major. There's a lot of people so worried about this phytonutrient or, you know, this type of tea versus that type of tea or, you know, this elixir or that elixir and I I I just think that they're they're getting lost in the wrong details. You know, they're they don't know their VO2 max and yet they are trying to tell me what their telomere length is.”
The primary success metric for longevity is not life expectancy alone but healthspan—the duration of healthy, high-quality life; this is personally driven for both Jason and Attia by family history of premature male death (fathers/grandfathers dying in 40s-50s), motivating intense focus on understanding and preventing the four horsemen.
“My passion for longevity uh more specifically healthspan stems from men in my family. You know, you you've shared this you know as well. Uh men in my family do not have a good track record with longevity. My father died of heart disease at 47. My maternal grandfather died of heart disease at 49. And my paternal grandfather died of cancer at 44. And I'm 48 and I have two little kids.”
Attia personally takes pravastatin (mild old statin) at low dose plus PCSK9 inhibitor (Repatha, approved 2015) and sometimes adds ezetimibe, using minimum effective doses of statin to minimize side effects while maximizing apoB-lowering efficacy.
“I take two actually. Um actually no, I'm I'm constantly changing my routine up. I'm I'm taking a drug called pravastatin, which is actually a very old statin, um but it's quite a mild statin. Um and I take a PCSK9 inhibitor called Repatha... for example, I'm not an enormous synthesizer of cholesterol. That's largely genetically determined and I don't make a lot of cholesterol. Um so, I'm not a person who wants to take a mega dose of a drug that impairs cholesterol synthesis. So, I take a relatively minor dose of a relatively weak version of that drug. And I get the most bang for my buck out of this PCSK9 inhibitor”
Attia's daily protein intake protocol: 8 egg whites + 4 yolks for breakfast (~40-45g), 5 venison jerky sticks for snack (~50g), protein shake with 50g whey in cashew milk, Greek yogurt with granola for another serving (~40-50g), plus meat/fish at dinner (~45g) = ~180-200g daily spread over 4 servings.
“I always make kind of 7:00 to 8:00 uh because I'm not trying to put on calories, uh like half of that is just white. So, it's like eight egg whites and four yolks gives me the right dose. Um my my favorite snack is venison sticks... each stick is 9.8 g, so call it 10. So, I'll have five of those sticks as a snack... And then a protein shake um for me is 50 g of whey protein in some cashew milk... So, I'll put that granola into, you know, 50 g worth of Greek yogurt”